NGL Fine-Chem has informed that the Fourth Board Meeting for the financial year 2023-24 of the Board of Directors of the company will be held on Monday, 12th February, 2024 at the Registered Office of the Company at 301, E-Square, Subhash Road, Vile Parle East, Mumbai 400057 to transact the following business: To approve the Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended on 31st December, 2023 and Any other business with the permission of the chair.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1912.90 |
| Dr. Reddys Labs. | 1387.55 |
| Cipla | 1465.95 |
| Zydus Lifesciences | 1132.45 |
| Lupin | 2468.40 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: